TY - BOOK ID - 146349529 TI - Actinobacteria and Myxobacteria : Important Resources for Novel Antibiotics PY - 2020 PB - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute DB - UniCat KW - Research & information: general KW - Biology, life sciences KW - actinomycetes KW - antibiotic biosynthesis KW - silent biosynthetic pathways KW - γ-butyrolactones KW - HiTES KW - translation inhibitors KW - marine actinobacteria KW - Streptomyces sp. KW - enzyme inhibition KW - antimicrobial KW - antioxidant KW - cytotoxicity KW - GC-MS KW - pyrrolopyrazines KW - myxobacteria KW - antivirals KW - secondary metabolites KW - HIV KW - Ebola KW - hepatitis viruses KW - diversity KW - uncultured KW - new antibiotics KW - Streptomyces KW - polyketides KW - secondary metabolite KW - polyketide synthases (PKSs) KW - actinomycetes KW - antibiotic biosynthesis KW - silent biosynthetic pathways KW - γ-butyrolactones KW - HiTES KW - translation inhibitors KW - marine actinobacteria KW - Streptomyces sp. KW - enzyme inhibition KW - antimicrobial KW - antioxidant KW - cytotoxicity KW - GC-MS KW - pyrrolopyrazines KW - myxobacteria KW - antivirals KW - secondary metabolites KW - HIV KW - Ebola KW - hepatitis viruses KW - diversity KW - uncultured KW - new antibiotics KW - Streptomyces KW - polyketides KW - secondary metabolite KW - polyketide synthases (PKSs) UR - https://www.unicat.be/uniCat?func=search&query=sysid:146349529 AB - Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units. ER -